易方达医药生物

Search documents
超40只主动权益基金一年翻倍 老牌权益大厂再现投资实力
Sou Hu Cai Jing· 2025-08-14 02:26
Core Viewpoint - The A-share market has shown a strong upward trend since July, with the Shanghai Composite Index surpassing 3600 points for the fourth time since 2007, 2015, and 2021, indicating a robust market recovery and investor sentiment improvement [1] Group 1: Market Performance - Since September 2024, A-shares and Hong Kong stocks have experienced a multi-sector rotation upward, with sectors like dividends, artificial intelligence, banking, and innovative pharmaceuticals showing active performance [1] - As of August 6, 2023, 80 actively managed equity funds have seen gains exceeding 60% this year, primarily from leading fund managers such as E Fund, Huitianfu, and GF Fund [2] - The AI and innovative pharmaceutical sectors have shown strong growth, with the CSI Artificial Intelligence Theme Index and the CSI Innovative Pharmaceutical Industry Index rising over 60% and 40% respectively in the past year [2] Group 2: Fund Performance - There are 43 equity funds that have doubled in value over the past year, with E Fund leading with four "doubling funds" [2][3] - As of August 6, 2023, 90 actively managed equity funds have achieved an annualized return of over 15% over the past three years, with E Fund having the highest number of such funds at seven [4][5] - The overall annualized return of the Wind All A Index is 3.19%, while the representative Wind Mixed Equity Fund Index has a return of -1.99% over the same period [6] Group 3: Sector Insights - The innovative pharmaceutical sector has seen a strong rebound after four years of stagnation, with several stocks doubling or tripling in value this year [7] - Fund managers believe the current market conditions for the innovative pharmaceutical sector are sustainable, with a focus on globally competitive pharma and biotech companies [7] - The technology sector, particularly cloud computing, is viewed as having long-term potential, although some fund managers anticipate adjustments due to prior gains [8]
破除「基金赚钱基民亏」魔咒,公募基金走到历史关口
3 6 Ke· 2025-05-12 10:07
公募基金"旱涝保收"的"好日子"终于要被强行扫进历史了。 近日,为落实2024年9月26日中央政治局会议"稳步推进公募基金改革"的决策部署,中国证监会印发《推动公募基金高质量发展行动方案》(下称《方 案》)。方案中的"基金公司考核激励方案改革调整"引发了业内最大的关注,其事关每个基金经理的生计,尤其是近些年陆续从"神坛"跌落的明星经理也 牵涉其中。 《方案》明确规定了,对三年以上产品的业绩低于业绩比较基准超过10个百分点的产品,要求其基金经理绩效薪酬应当明显下降;且规定了未来一年内, 管理规模靠前的头部公募发行浮动管理费收取机制的基金数量,不得低于其主动权益类基金发行数量的60%。 据Wind统计,目前仅有138只公募基金产品收取浮动管理费,其中有49只为偏股混合或普通股票型基金,相较于市场整体数量较少。此次《方案》的力 度,可以说是"伤筋动骨"。 中信建投证券在最新的详解报告中称,此举意在解决"基金赚钱基民不赚钱"的问题。 南方基金总经理杨小松对《凤凰WEEKLY财经》介绍《方案》出台的背景:"在宏观经济形势变化、基础资产市场波动等背景下,部分基金的中长期业绩 不及预期或者投资表现与业绩比较基准存在偏离,导 ...